Product image of Ondansan (Ondansetron) supplied by GNH India

Ondansan

Active Ingredient:
Ondansetron
Origin:
EU

Ondansan (Ondansetron)

Ondansetron, the active ingredient in Ondansan, is a 5‑HT3 receptor antagonist presented as an oral tablet for oral use. It is employed to prevent and treat nausea and vomiting caused by chemotherapy, radiotherapy, and postoperative recovery in adult patients.

GNH India supplies Ondansan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide, ensuring consistent quality and regulatory compliance for global distribution. The company adheres to EU GMP standards and provides reliable logistics for timely delivery to clinical sites.

Manufacturer / TM Owner

G.L. Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ondansan, a 5‑HT3 receptor antagonist, is indicated for several types of nausea and vomiting.

  • Chemotherapy‑induced nausea and vomiting: helps prevent and control nausea and vomiting in patients undergoing cancer chemotherapy.
  • Radiotherapy‑induced nausea and vomiting: reduces the frequency of nausea and vomiting associated with radiation treatment.
  • Postoperative nausea and vomiting: used to lessen nausea and vomiting after surgical procedures.

How It Works

  • Ondansetron selectively blocks serotonin (5‑HT3) receptors located in the chemoreceptor trigger zone of the brain and in the gastrointestinal tract. By antagonizing these receptors, it interrupts the signaling cascade that initiates the vomiting reflex, thereby decreasing the sensation of nausea and the act of vomiting.

Side Effects

Ondansan may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects

  • Headache: mild to moderate pain in the head.
  • Constipation: reduced bowel movements or hard stools.
  • Diarrhoea: loose, watery stools.
  • Fatigue: feeling unusually tired or weak.

Serious or Rare Side Effects

  • QT interval prolongation: potential heart rhythm disturbance.
  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Serotonin syndrome: rare but serious condition when combined with other serotonergic agents.

Precautions & Warnings

Before using Ondansan, consider the following precautions.

  • Renal impairment: dose adjustment may be required in patients with severe kidney dysfunction.
  • Hepatic impairment: monitor liver function and adjust dose if necessary.
  • Concomitant QT‑prolonging drugs: avoid or monitor closely due to risk of cardiac arrhythmia.
  • Electrolyte disturbances: correct low potassium or magnesium levels to reduce cardiac risk.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Avoid Interactions

Ondansan can interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid)

  • Apomorphine: can cause profound hypotension and loss of consciousness.
  • Certain antiarrhythmic agents (e.g., amiodarone, quinidine): may markedly increase QT prolongation risk.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise ondansetron plasma levels.
  • CYP2D6 substrates (e.g., tramadol, codeine): potential for altered metabolism.
  • Other serotonergic drugs (e.g., SSRIs, tramadol): monitor for signs of serotonin syndrome.

Frequently Asked Questions

Ondansan contains ondansetron, an antiemetic used to prevent and treat nausea and vomiting that can occur after chemotherapy, radiotherapy, or surgery. It is prescribed for adult patients who are at risk of these symptoms during cancer treatment or postoperative recovery.

Ondansetron works by selectively blocking serotonin 5‑HT3 receptors in the brain’s chemoreceptor trigger zone and in the gastrointestinal tract. This inhibition stops the nerve signals that trigger the vomiting reflex, thereby reducing both nausea and vomiting.

The specific dose of Ondansan is determined by the prescribing clinician based on the patient’s condition, treatment plan, and individual health factors. Healthcare professionals set the appropriate regimen and timing for each patient.

Safety data for ondansetron in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Ondansan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ondansan (ondansetron) belongs to the 5‑HT3 antagonist class, which is generally more effective for chemotherapy‑induced nausea than dopamine antagonists such as metoclopramide. It has a different side‑effect profile, with fewer extrapyramidal symptoms but a potential for QT prolongation.

Ondansan should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Ondansan is supplied as an oral tablet. The tablet should be swallowed whole with a glass of water, preferably on an empty stomach unless otherwise directed by the prescriber.

Serious risks include QT interval prolongation, which can lead to cardiac arrhythmias, and rare severe allergic reactions such as anaphylaxis. Patients should be monitored for any signs of heart rhythm changes or hypersensitivity.

Ondansan is contraindicated in individuals with known hypersensitivity to ondansetron or any component of the formulation. Caution is also advised for patients taking other QT‑prolonging agents or those with significant electrolyte imbalances.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ondansetron

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT